News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
Leap Therapeutics and Flagship Biosciences Develop Image Analysis RNAscope Assay for Prospective Trial Enrollment
Cambridge, Massachusetts and Westminster, Colorado (May 12, 2021) — Leap Therapeutics (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, and Flagship Biosciences,
Flagship Biosciences and Leap Therapeutics Announce Partnership and Approach Using RNAscope and Image Analysis for Patient Enrollment
Laboratory Developed Test for Manual and Image Analysis-assisted Pathologist Interpretation Westminster, Colorado and Cambridge, Massachusetts (April 12, 2021) — Flagship Biosciences, the leader in data-centric
Flagship Biosciences Announces Strategic Executive Team Additions
Dr. Roberto Gianani and Michael Koratich Named to Key Medical and Pharma Roles Westminster, Colorado (March 10, 2021) — Flagship Biosciences, the leader in data-centric
Flagship Biosciences Announces Patent
Patent Number 10,839,512 Issued for New Tissue Sample Image Dot Detection Method Westminster, CO (February 17, 2021) — Flagship Biosciences, the leader in data-centric pathology
Inspirata and Flagship Biosciences Announce New Technical Partnership and Integration at Pathology Visions 2020
The new technical partnership between Inspirata and Flagship Biosciences provides clinicians with a seamless, fully automated AI send-out solution, offering significant advantages over standard material
Accelerating Drug Development as a Top Image Analysis Solution Provider for 2020
As featured in Pharma Tech Outlook Magazine, July 2020 Flagship Biosciences was recently selected as a Top Image Analysis Solution Provider for 2020 by Pharma
